Figure 1From: Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial Overall survival in patients treated with late course of accelerated hyperfractionated irradiation (LCAF) alone (dashed line) or LCAF with concurrent chemotherapy (LCAF + CT) (solid line). Back to article page